title: Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment.
authors.affiliation: Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom Department of Haematology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Pawlyn
authors.affiliation: Department of Gastroenterology, Royal Marsden Hospital, London, United Kingdom Department of Gastroenterology, University of Wales Hospital, Cardiff, United Kingdom.
authors.forename: Mohid S
authors.initials: MS
authors.lastname: Khan
authors.affiliation: Department of Gastroenterology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: Ann
authors.initials: A
authors.lastname: Muls
authors.affiliation: Department of Haematology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: Priya
authors.initials: P
authors.lastname: Sriskandarajah
authors.affiliation: Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom Department of Haematology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: Martin F
authors.initials: MF
authors.lastname: Kaiser
authors.affiliation: Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom Department of Haematology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: Faith E
authors.initials: FE
authors.lastname: Davies
authors.affiliation: Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom Department of Haematology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: Gareth J
authors.initials: GJ
authors.lastname: Morgan
authors.affiliation: Department of Gastroenterology, Royal Marsden Hospital, London, United Kingdom.
authors.forename: H Jervoise N
authors.initials: HJ
authors.lastname: Andreyev
mesh_terms: D000368:Aged; D001647:Bile Acids and Salts / Q000378:metabolism*; D003967:Diarrhea / Q000139:chemically induced*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008286:Malabsorption Syndromes / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D001647:Bile Acids and Salts; D013792:Thalidomide; D000077269:Lenalidomide